Clinical

Dataset Information

0

Immunotherapy for Third Line Metastatic Colorectal Cancer


ABSTRACT: This is a Phase IIB multi-site, open label study of a next generation immunotherapy for third-line MSI-S metastatic colorectal cancer using an "off-the-shelf", non-genetically manipulated living immune cell product (AlloStim) derived from the blood of healthy donors.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2343551 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| PRJEB53321 | ENA
2016-01-07 | E-MTAB-3825 | biostudies-arrayexpress
2015-06-04 | E-GEOD-61887 | biostudies-arrayexpress
2016-08-18 | E-MTAB-3859 | biostudies-arrayexpress
2008-05-07 | E-GEOD-5104 | biostudies-arrayexpress
2015-06-04 | GSE61887 | GEO
2023-03-09 | GSE180394 | GEO
2023-03-09 | GSE180393 | GEO
2022-10-26 | GSE216455 | GEO
2008-06-17 | E-GEOD-997 | biostudies-arrayexpress